Advertisement

Pulmonary arterial hypertension and chronic thromboembolic pulmonary hypertension incidence in Latvia in 2021 according to the new definition

Published:August 29, 2022DOI:https://doi.org/10.1016/j.ejim.2022.08.030

      Highlights

      • PH at the time of diagnosis has already progressed.
      • Most of the PAH patients are in the intermediate risk group.
      • PAH and CTEPH incidence generally is stable over the last 5 years.

      Keywords

      To read this article in full you will need to make a payment

      Purchase one-time access:

      Academic & Personal: 24 hour online accessCorporate R&D Professionals: 24 hour online access
      One-time access price info
      • For academic or personal research use, select 'Academic and Personal'
      • For corporate R&D use, select 'Corporate R&D Professionals'

      Subscribe:

      Subscribe to European Journal of Internal Medicine
      Already a print subscriber? Claim online access
      Already an online subscriber? Sign in
      Institutional Access: Sign in to ScienceDirect

      References

        • Condon D.F.
        • Nickel N.P.
        • Anderson R.
        • Mirza S.
        • de J.
        • Perez V.A.
        The 6th world symposium on pulmonary hypertension: what's old is new.
        F1000Res. 2019; 8 (Jun 19F1000 Faculty Rev-888PMID: 31249672; PMCID: PMC6584967)https://doi.org/10.12688/f1000research.18811.1
        • Leber L.
        • Beaudet A.
        • Muller A.
        Epidemiology of pulmonary arterial hypertension and chronic thromboembolic pulmonary hypertension: identification of the most accurate estimates from a systematic literature review.
        Pulm Circ. 2021; 11 (Jan 72045894020977300PMID: 33456755; PMCID: PMC7797595)https://doi.org/10.1177/2045894020977300
        • Chang K.Y.
        • Duval S.
        • Badesch D.B.
        • Bull T.M.
        • Chakinala M.M.
        • De Marco T.
        • Frantz R.P.
        • Hemnes A.
        • Mathai S.C.
        • Rosenzweig E.B.
        • Ryan J.J.
        • Thenappan T.
        • Investigators * P.H.A.R.
        Mortality in pulmonary arterial hypertension in the modern era: early insights from the pulmonary hypertension association registry.
        J Am Heart Assoc. 2022; 11 (May 3Epub 2022 Apr 27. PMID: 35475351; PMCID: PMC9238604)e024969https://doi.org/10.1161/JAHA.121.024969
        • Marques-Alves P.
        • Baptista R.
        • Marinho da Silva A.
        • Pêgo M.
        • Castro G.
        Real-world, long-term survival of incident patients with pulmonary arterial hypertension.
        Rev Port Pneumol. 2017; 23 (2006)May-JunEpub 2017 Mar 7. PMID: 28283462: 124-131https://doi.org/10.1016/j.rppnen.2017.01.006
        • Kerr K.
        • Auger W.
        • Madani M.
        United States chronic thromboembolic pulmonary hypertension registry.
        Chest. 2015; 148: 1008Ahttps://doi.org/10.1378/chest.2260222
        • Delcroix M.
        • Lang I.
        • Pepke-Zaba J.
        • Jansa P.
        • D'Armini A.M.
        • Snijder R.
        • Bresser P.
        • Torbicki A.
        • Mellemkjaer S.
        • Lewczuk J.
        • Simkova I.
        • Barberà J.A.
        • de Perrot M.
        • Hoeper M.M.
        • Gaine S.
        • Speich R.
        • Gomez-Sanchez M.A.
        • Kovacs G.
        • Jaïs X.
        • Ambroz D.
        • Treacy C.
        • Morsolini M.
        • Jenkins D.
        • Lindner J.
        • Dartevelle P.
        • Mayer E.
        • Simonneau G.
        Long-term outcome of patients with chronic thromboembolic pulmonary hypertension: results from an international prospective registry.
        Circulation. 2016; 133 (Mar 1Epub 2016 Jan 29. PMID: 26826181): 859-871https://doi.org/10.1161/CIRCULATIONAHA.115.016522
        • Leuchte H.H.
        • Ten Freyhaus H.
        • Gall H.
        • Halank M.
        • Hoeper M.M.
        • Kaemmerer H.
        • et al.
        Risk stratification strategy and assessment of disease progression in patients with pulmonary arterial hypertension: updated recommendations from the cologne consensus conference 2018.
        Int J Cardiol. 2018; (Dec 1Epub 2018 Sep 13. PMID: 30266353): 20-29https://doi.org/10.1016/j.ijcard.2018.08.084
        • Kigitovica D.
        • Sablinskis M.
        • Sablinskis K.
        • Rudzitis A.
        • Skride A.
        Pulmonary arterial hypertension and chronic thromboembolic pulmonary hypertension incidence in Latvia in 2018.
        Eur J Intern Med. 2019; 65 (JulEpub 2019 May 14. PMID: 31101467): e9-e10https://doi.org/10.1016/j.ejim.2019.04.022
        • Sablinskis K.
        • Sablinskis M.
        • Lejnieks A.
        • Skride A.
        Growing number of incident pulmonary arterial hypertension and chronic thromboembolic pulmonary hypertension patients in Latvia: a shifting epidemiological landscape? Data from a national pulmonary hypertension registry.
        Eur J Intern Med. 2019; 59 (JanEpub 2018 Sep 29. PMID: 30279036): e16-e17https://doi.org/10.1016/j.ejim.2018.09.017